TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins

[1]  O. Nilsson,et al.  Characterization of Monoclonal Antibodies Directed against Squamous Cell Carcinoma Antigens: Report of the Second TD-10 Workshop , 2009, Tumor Biology.

[2]  M. Leite,et al.  Biological and methodological features of the measurement of S100B, a putative marker of brain injury. , 2008, Clinical biochemistry.

[3]  C. Gottfried,et al.  A simple, sensitive and widely applicable ELISA for S100B: Methodological features of the measurement of this glial protein , 2008, Journal of Neuroscience Methods.

[4]  G. Shaw,et al.  Calcium-dependent and -independent interactions of the S100 protein family. , 2006, The Biochemical journal.

[5]  D. Souza,et al.  The ischemic rat heart releases S100B. , 2005, Life sciences.

[6]  A. Fersht,et al.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Mikalsen,et al.  Immunofluorometric Assay for the Metastasis-Related Protein S100A4: Release of S100A4 from Normal Blood Cells Prohibits the Use of S100A4 as a Tumor Marker in Plasma and Serum , 2004, Tumor Biology.

[8]  O. Nilsson,et al.  Characterization of Monoclonal Antibodies Directed against Squamous Cell Carcinoma Antigens: Report of the TD-10 Workshop , 2004, Tumor Biology.

[9]  F. Michetti,et al.  S100B protein in biological fluids: a tool for perinatal medicine. , 2002, Clinical chemistry.

[10]  David J Weber,et al.  Solution structure of human Mts1 (S100A4) as determined by NMR spectroscopy. , 2002, Biochemistry.

[11]  J. Kuźnicki,et al.  CacyBP/SIP, a Calcyclin and Siah-1-interacting Protein, Binds EF-hand Proteins of the S100 Family* , 2002, The Journal of Biological Chemistry.

[12]  R. Donato,et al.  Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles , 2002, Neuroscience.

[13]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[14]  G. Selivanova,et al.  Tumor Suppressor p53 Protein Is a New Target for the Metastasis-associated Mts1/S100A4 Protein , 2001, The Journal of Biological Chemistry.

[15]  L. Hansson,et al.  Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  David J Weber,et al.  SOLUTION STRUCTURE OF THE C-TERMINAL NEGATIVE REGULATORY DOMAIN OF P53 IN A COMPLEX WITH CA2+-BOUND S100B(BB) , 2000 .

[17]  K. Haglid,et al.  A New Specific Method for Measuring S-100B in Serum , 2000, The International journal of biological markers.

[18]  A. Ebert,et al.  Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. , 1999, Stroke.

[19]  A. Hauschild,et al.  S100B Protein Detection in Serum Is a Significant Prognostic Factor in Metastatic Melanoma , 1999, Oncology.

[20]  A. Raabe,et al.  Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. , 1998, Stroke.

[21]  R. Donato,et al.  Annexin VI binds S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments. , 1998, Cell calcium.

[22]  C. Blomstrand,et al.  Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. , 1998, Stroke.

[23]  D. Zimmer,et al.  The S100 protein family: History, function, and expression , 1995, Brain Research Bulletin.

[24]  C. Heizmann,et al.  Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. , 1995, Genomics.

[25]  K. Nustad,et al.  Immunoradiometric assay for alpha gamma- and gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles. , 1989, Clinical chemistry.

[26]  B. Moore.  A soluble protein characteristic of the nervous system. , 1965, Biochemical and biophysical research communications.

[27]  C. Heizmann.  S100B protein in clinical diagnostics: assay specificity. , 2004, Clinical chemistry.

[28]  S. Ottó,et al.  Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma. , 2003, European journal of cancer.

[29]  B. Romner,et al.  The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. , 2000, Brain injury.

[30]  Y. Ohtsuki,et al.  Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues. , 1984, Virchows Archiv. B, Cell pathology including molecular pathology.

[31]  Y. Ohtsuki,et al.  Immunohistochemical study on the distribution of α and β subunits of S-100 protein in human neoplasm and normal tissues , 1984 .